Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Cytarabine can cause multiple organ toxicities, especially neurotoxicity, but better research methods are needed to fully understand and predict these effects.

Upadacitinib may effectively treat resistant lichen planopilaris.

A new triple drug system using nanoparticles effectively targets breast tumors in 3D models.

Older patients without prior JAK inhibitor treatment respond best to tofacitinib for alopecia areata.

TGF-β inhibitors may help treat liver fibrosis by targeting various pathways.

Baricitinib improved severe hair loss in adults over 52 weeks and was safe to use.

Blocking mTORC1 activity with rapamycin could help increase hair pigmentation and growth, potentially reversing gray hair.

A woman's hair turned gray and fell out after starting a cancer drug called imatinib mesylate.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Targeted anticancer therapies often cause skin issues, affecting treatment adherence and quality of life.

Targeted cancer therapies often cause serious skin problems that need careful management.

Ritlecitinib effectively regrows and maintains scalp, eyebrow, and eyelash hair in alopecia areata patients.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Baricitinib is the most effective treatment for alopecia areata.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

TYK2 inhibition may help treat alopecia areata by promoting hair growth and reducing immune response.

JAK inhibitors may help improve symptoms in adults with APECED.

Janus kinase inhibitors may help treat cutaneous T-cell lymphoma, but more research is needed.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Baricitinib successfully treated severe hair loss.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Avacopan may cause unexpected side effects, so early monitoring is important.

Calcineurin inhibitors, used in kidney transplants, can cause a wide range of side effects including kidney damage and other health issues.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.